Javier Salvador Bofill

4PUBLICATIONS
28CO-AUTHORS
Molecular targetsPredictive and prognostic markersMotor controlCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 01, 2025
Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with PIK3CA Mutations: The Phase Ib SOLTI-1507 IPATHER Trial.

Mafalda Oliveira, Eva Ciruelos, Guillermo Villacampa

|Jan 25, 2025
Early Myocardial Strain Reduction and miR-122-5p Elevation Associated with Interstitial Fibrosis in Anthracycline-Induced Cardiotoxicity.

María de Regla Caballero-Valderrama, Elisa Bevilacqua, Miriam Echevarría

|May 27, 2023
Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer.

Mónica Cejuela, Ana Gil-Torralvo, M Ángeles Castilla

Pageof 1